生长受限胎儿的孕中期心血管生物测量:一项多中心队列研究
该研究为哥本哈根婴儿心脏研究的子研究,前瞻性多中心纳入8278例孕中期胎儿,产后按ISUOG 2020指南分为小于胎龄儿625例(7.6%)和宫内生长受限289例(3.5%)。两组胎儿心脏生物测量均较小,宫内生长受限组在调整腹围后主动脉瓣和肺动脉瓣差异仍显著;心脏生物测量单独筛查效果有限,联合其他因素可提高灵敏度和特异度。
要点
- 小于胎龄儿和宫内生长受限胎儿孕中期心脏生物测量均较小。
- 宫内生长受限组在调整腹围后主动脉瓣和肺动脉瓣差异仍显著。
- 心脏生物测量单独筛查效果有限,联合其他因素可提高灵敏度和特异度。
核心结论
- 宫内生长受限胎儿产前心血管生物测量较小,即使调整腹围后仍如此。
- 研究结果支持生长受限在妊娠早期即已与心脏生长改变相关。
- 心脏生物测量单独作为筛查试验表现良好,但联合其他因素可提高对宫内生长受限的灵敏度和特异度。
研究设计与样本
- 本研究为哥本哈根婴儿心脏研究(Copenhagen Baby Heart Study)的子研究,是一项前瞻性多中心队列研究。
- 纳入2016年4月至2018年10月哥本哈根孕中期胎儿,在孕中期解剖扫描时招募,扫描包括扩展心血管图像记录,随后由2名对妊娠结局设盲的研究者连续测量心脏生物测量。
- 胎儿产后根据国际妇产科超声学会(ISUOG)2020指南使用出生体重并回顾性评估多普勒血流,分类为小于胎龄儿和宫内生长受限。
- 共纳入8278例胎儿,其中小于胎龄儿625例(7.6%),宫内生长受限289例(3.5%)。
- 心血管生物测量的平均差异调整了孕中期扫描时的孕龄和腹围;计算z评分,比较采用Bonferroni校正(显著性水平P<.005);对若干母亲特征和生物标志物进行后退回归后计算受试者工作特征曲线。
主要发现
- 小于胎龄儿和宫内生长受限胎儿均具有较小的心脏生物测量,包括主动脉瓣处直径(P<.005)、三血管切面升主动脉(P<.005)和肺动脉瓣处(P<.005)。
- 宫内生长受限组心脏长度和宽度显著较小(P<.005),左右心室也较小(P<.005)。
- 调整腹围后,宫内生长受限组主动脉瓣和肺动脉瓣的差异仍显著。
- 获得最佳受试者工作特征曲线的参数包括:头围、腹围、股骨长度、孕龄、妊娠相关血浆蛋白-A中位数倍数、未产、自然受孕、吸烟、体重指数<18.5、心脏宽度和肺动脉瓣,对宫内生长受限病例的曲线下面积为0.91(0.88-0.93)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrauterine growth restriction is associated with an increased risk of cardiovascular changes neonatally. However, the underlying pathways are poorly understood, and it is not clear whether the dysfunction is already present in the fetus. OBJECTIVE: This study aimed to investigate fetal cardiac dimensions assessed from images at the second trimester anatomy scan from fetuses classified postnatally as small for gestational age and intrauterine growth restricted and compare them with appropriate for gestational age fetuses. STUDY DESIGN: This was a substudy from The Copenhagen Baby Heart Study, a prospective, multicenter cohort study including fetuses from the second trimester of pregnancy in Copenhagen from April 2016 to October 2018. The mothers were recruited at the second trimester anatomy scan that included extended cardiovascular image documentation followed by consecutively measured heart biometry by 2 investigators blinded for the pregnancy outcome. The fetuses were classified postnatally as small for gestational age and intrauterine growth restricted according to the International Society of Ultrasound in Obstetrics and Gynecology 2020 guidelines using birthweight and with a retrospective assessment of Doppler flow. The mean differences in the cardiovascular biometry were adjusted for gestational age at the time of the second trimester scan and the abdominal circumference. The z-scores were calculated, and the comparisons were Bonferroni corrected (significance level of P<.005). Receiver operating characteristic curves were computed after performing backward regression on several maternal characteristics and biomarkers. RESULTS: We included 8278 fetuses, with 625 (7.6%) of them being small for gestational age and 289 (3.5%) being intrauterine growth restricted. Both small for gestational age and intrauterine growth restricted fetuses had smaller heart biometry, including the diameter at the location of the aortic valve (P<.005), the ascending aorta in the 3-vessel view (P<.005), and at the location of the pulmonary valve (P<.005). The intrauterine growth restricted group had significantly smaller hearts with respect to length and width (P<.005) and smaller right and left ventricles (P<.005). After adjusting for the abdominal circumference, the differences in the aortic valve and the pulmonary valve remained significant in the intrauterine growth restricted group. Achievement of an optimal receiver operating characteristic curve included the following parameters: head circumference, abdominal circumference, femur length, gestational age, pregnancy associated plasma protein-A multiples of median, nullipara, spontaneous conception, smoking, body mass index <18.5, heart width, and pulmonary valve with an area under the curve of 0.91 (0.88-0.93) for intrauterine growth restricted cases. CONCLUSION: Intrauterine growth restricted fetuses had smaller prenatal cardiovascular biometry, even when adjusting for abdominal circumference. Our findings support that growth restriction is already associated with altered cardiac growth at an early stage of pregnancy. The heart biometry alone did perform well as a screening test, but combined with other factors, it increased the sensitivity and specificity for intrauterine growth restriction.
引用
- Frandsen JS, Gadsbøll K, Jørgensen FS, et al. Second-trimester cardiovascular biometry in growth-restricted fetuses; a multicenter cohort study. Am J Obstet Gynecol. 2021. PMID: 34951985. doi:10.1016/j.ajog.2021.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。